SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001566044-21-000012
Filing Date
2021-03-04
Accepted
2021-03-04 09:21:39
Documents
52
Period of Report
2021-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-20210304.htm   iXBRL 8-K 34097
2 EX-99.1 investorpresentation2020.htm EX-99.1 45442
8 GRAPHIC investorpresentation2020001.jpg GRAPHIC 117692
9 GRAPHIC investorpresentation2020002.jpg GRAPHIC 173647
10 GRAPHIC investorpresentation2020003.jpg GRAPHIC 106360
11 GRAPHIC investorpresentation2020004.jpg GRAPHIC 91842
12 GRAPHIC investorpresentation2020005.jpg GRAPHIC 97461
13 GRAPHIC investorpresentation2020006.jpg GRAPHIC 123227
14 GRAPHIC investorpresentation2020007.jpg GRAPHIC 102364
15 GRAPHIC investorpresentation2020008.jpg GRAPHIC 72603
16 GRAPHIC investorpresentation2020009.jpg GRAPHIC 86079
17 GRAPHIC investorpresentation2020010.jpg GRAPHIC 120836
18 GRAPHIC investorpresentation2020011.jpg GRAPHIC 87714
19 GRAPHIC investorpresentation2020012.jpg GRAPHIC 94781
20 GRAPHIC investorpresentation2020013.jpg GRAPHIC 100582
21 GRAPHIC investorpresentation2020014.jpg GRAPHIC 86898
22 GRAPHIC investorpresentation2020015.jpg GRAPHIC 111844
23 GRAPHIC investorpresentation2020016.jpg GRAPHIC 85329
24 GRAPHIC investorpresentation2020017.jpg GRAPHIC 73913
25 GRAPHIC investorpresentation2020018.jpg GRAPHIC 74034
26 GRAPHIC investorpresentation2020019.jpg GRAPHIC 74046
27 GRAPHIC investorpresentation2020020.jpg GRAPHIC 77808
28 GRAPHIC investorpresentation2020021.jpg GRAPHIC 105816
29 GRAPHIC investorpresentation2020022.jpg GRAPHIC 117376
30 GRAPHIC investorpresentation2020023.jpg GRAPHIC 75458
31 GRAPHIC investorpresentation2020024.jpg GRAPHIC 76282
32 GRAPHIC investorpresentation2020025.jpg GRAPHIC 113160
33 GRAPHIC investorpresentation2020026.jpg GRAPHIC 101680
34 GRAPHIC investorpresentation2020027.jpg GRAPHIC 118838
35 GRAPHIC investorpresentation2020028.jpg GRAPHIC 102814
36 GRAPHIC investorpresentation2020029.jpg GRAPHIC 136454
37 GRAPHIC investorpresentation2020030.jpg GRAPHIC 120496
38 GRAPHIC investorpresentation2020031.jpg GRAPHIC 102747
39 GRAPHIC investorpresentation2020032.jpg GRAPHIC 94905
40 GRAPHIC investorpresentation2020033.jpg GRAPHIC 118878
41 GRAPHIC investorpresentation2020034.jpg GRAPHIC 80799
42 GRAPHIC investorpresentation2020035.jpg GRAPHIC 159858
43 GRAPHIC investorpresentation2020036.jpg GRAPHIC 150104
44 GRAPHIC investorpresentation2020037.jpg GRAPHIC 50150
  Complete submission text file 0001566044-21-000012.txt   5461233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlo-20210304.xsd EX-101.SCH 2547
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlo-20210304_cal.xml EX-101.CAL 821
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlo-20210304_def.xml EX-101.DEF 1785
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlo-20210304_lab.xml EX-101.LAB 25280
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlo-20210304_pre.xml EX-101.PRE 13298
45 EXTRACTED XBRL INSTANCE DOCUMENT mnlo-20210304_htm.xml XML 11687
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 21712738
SIC: 2834 Pharmaceutical Preparations